The process of photosynthesis enables plants to grow and propagate as long as the environment provides soil, water, sunlight, and air. The growth process proves slow though, and in the case of cannabis, naturally grown marijuana produces only two major cannabinoids, THC and CBD.
Biosynthesis Helps Researchers Explore the Minor Cannabinoids
Although the plant produces many minor cannabinoids, they appear in quantities too small to make them viable to pursue pharmaceutical applications. Using the biosynthesis process, cannabinoid biosynthesis companies influences growth using yeast. It simply speeds the process, allowing the firms to grow larger amounts of cannabis for studies to uncover potential uses of the minor cannabinoids.
For example, THCv inhibits appetite although it develops in the same plant as THC, the appetite stimulant. Another example, CBC, exhibits anti-inflammatory properties and offers immune system support.
Marijuana’s Rich Possibilities
More than 100 minor cannabinoids exist. They haven’t yet been studied in-depth though, because of the roadblocks to obtaining enough of each substance. Biosynthesis addresses this problem, creating synthetic cannabis with the same properties as naturally grown cannabis. Researchers can use the synthetically developed marijuana for research into the minor cannabinoids to unlock future uses of this common and easy-to-cultivate plant.